ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - dexamethasone - שתל במתקן להחדרת תרופה - dexamethasone 0.7 mg - dexamethasone - dexamethasone - ozurdex is indicated for the treatment of adult patients with macular edema following either branch retinal vein occlusion (brvo) or central retinal vein occlusion (crvo).ozurdex is indicated for the treatment of adult patients with inflammation of the posterior segment of the eye presenting as non-infectious uveitis.

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - budesonide - תרחיף לשאיפה - budesonide 0.25 mg / 1 ml - budesonide - budesonide - bronchial asthma especially in cases where other therapy is insufficient or insuitable.

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - budesonide - תרחיף לשאיפה - budesonide 0.5 mg / 1 ml - budesonide - budesonide - bronchial asthma especially in cases where other therapy is insufficient of unsuitable.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - תרחיף - fluticasone propionate 0.05 g / 100 g - fluticasone - fluticasone - prophylaxis and treatment of seasonal allergic rhinitis including hayfever, and perennial rhinitis. perenial rhinitis in children of the age of 4 years.

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fluticasone propionate - תרחיף - fluticasone propionate 0.05 %w/w - fluticasone - fluticasone - prophylaxis and treatment of seasonal allergic rhinitis including hay fever and perenial rhinitis.

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fluticasone propionate - תמיסה לאף - fluticasone propionate 0.05 %w/w - fluticasone - fluticasone - prophylaxis and treatment of seasonal allergic rhinitis including hay fever and perenial rhinitis.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone furoate - ספריי - fluticasone furoate 27.5 mcg/dose - fluticasone furoate - fluticasone - avamys (fluticasone furoate) nasal spray is indicated for the treatment of the symptoms of seasonal and perennial allergic rhinitis in patients aged 2 years and older.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.05 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.125 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.25 mg/dose; formoterol fumarate dihydrate 0.01 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.